Viridian Therapeutics
VRDN
VRDN
178 hedge funds and large institutions have $1.75B invested in Viridian Therapeutics in 2024 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 79 increasing their positions, 42 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1.06% more ownership
Funds ownership: 113.88% → 114.94% (+1.1%)
12% less capital invested
Capital invested by funds: $1.98B → $1.75B (-$233M)
52% less call options, than puts
Call options by funds: $9.76M | Put options by funds: $20.4M
Holders
178
Holding in Top 10
12
Calls
$9.76M
Puts
$20.4M
Top Buyers
| 1 | +$26.8M | |
| 2 | +$24.6M | |
| 3 | +$21.9M | |
| 4 |
BlackRock
New York
|
+$18.3M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$15.6M |
Top Sellers
| 1 | -$44.6M | |
| 2 | -$25.4M | |
| 3 | -$20.6M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$15.6M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$13.3M |